{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:46:05Z","timestamp":1789706765009,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.atherosclerosis.2017.07.030","type":"journal-article","created":{"date-parts":[[2017,7,29]],"date-time":"2017-07-29T06:47:30Z","timestamp":1501310850000},"page":"22-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Alterations in plasma triglycerides lipolysis in patients with history of multifactorial chylomicronemia"],"prefix":"10.1016","volume":"265","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4916-6613","authenticated-orcid":false,"given":"Oriane","family":"Marmontel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Di Filippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Marcais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Nony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Dumoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Serveaux-Dancer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrielle","family":"Caussy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sybil","family":"Charri\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.atherosclerosis.2017.07.030_bib1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S2213-8587(13)70191-8","article-title":"The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management","volume":"2","author":"Hegele","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.07.030_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.atherosclerosis.2011.06.028","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"217","author":"Catapano","year":"2011","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.07.030_bib3","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2015.26","article-title":"Chylomicronaemia\u2013current diagnosis and future therapies","volume":"11","author":"Brahm","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.07.030_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2796.2012.02516.x","article-title":"Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia","volume":"272","author":"Surendran","year":"2012","journal-title":"J.\u00a0Intern Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.07.030_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.atherosclerosis.2015.04.815","article-title":"Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia","volume":"241","author":"Rabacchi","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.07.030_bib6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12944-016-0251-2","article-title":"Frequency of rare mutations and common genetic variations in severe hypertriglyceridemia in the general population of Spain","volume":"15","author":"Lamiquiz-Moneo","year":"2016","journal-title":"Lipids Health Dis."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2017.07.030_bib7","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1210\/jc.2011-3213","article-title":"Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline","volume":"97","author":"Berglund","year":"2012","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2017.07.030_bib8","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.bbalip.2011.10.007","article-title":"Allelic and phenotypic spectrum of plasma triglycerides","volume":"1821","author":"Johansen","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.07.030_bib9","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1161\/CIRCGENETICS.114.000522","article-title":"Common genetic variants contribute to primary hypertriglyceridemia without differences between familial combined hyperlipidemia and isolated hypertriglyceridemia","volume":"7","author":"De Castro-Or\u00f3s","year":"2014","journal-title":"Circ. Cardiovasc Genet."},{"key":"10.1016\/j.atherosclerosis.2017.07.030_bib10","series-title":"Endotext [Internet]","article-title":"Genetic disorders of triglyceride metabolism","author":"Chait","year":"2000"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2017.07.030_bib11","doi-asserted-by":"crossref","first-page":"e96482","DOI":"10.1371\/journal.pone.0096482","article-title":"Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects","volume":"9","author":"Di Filippo","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.07.030_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0003-2697(87)90541-0","article-title":"An enzyme-linked immunoassay for lipoprotein lipase","volume":"166","author":"Goers","year":"1987","journal-title":"Anal. Biochem."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2017.07.030_bib13","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/S0022-2275(20)41166-6","article-title":"Establishment of enzyme-linked immunosorbent assays for lipoprotein lipase with newly developed antibodies","volume":"35","author":"Kawamura","year":"1994","journal-title":"J.\u00a0Lipid Res."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.07.030_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0009-9120(98)00081-2","article-title":"Development and evaluation of a direct sandwich enzyme-linked immunosorbent assay for the quantification of lipoprotein lipase mass in human plasma","volume":"32","author":"Kimura","year":"1999","journal-title":"Clin. Biochem."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.07.030_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1161\/CIRCGENETICS.109.908905","article-title":"Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects","volume":"3","author":"Franssen","year":"2010","journal-title":"Circ. Cardiovasc Genet."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.07.030_bib16","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1194\/jlr.M002717","article-title":"Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia","volume":"51","author":"Olivecrona","year":"2010","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2017.07.030_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-230X-9-46","article-title":"Lipoprotein lipase activity and mass, apolipoprotein C-II mass and polymorphisms of apolipoproteins E and A5 in subjects with prior acute hypertriglyceridaemic pancreatitis","volume":"9","author":"Coca-Prieto","year":"2009","journal-title":"BMC Gastroenterol."},{"issue":"1\u20132","key":"10.1016\/j.atherosclerosis.2017.07.030_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0009-8981(93)90144-S","article-title":"Lipoprotein lipase mass and activity in severe hypertriglyceridemia","volume":"216","author":"Kobayashi","year":"1993","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2017.07.030_bib19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2362.1989.tb00255.x","article-title":"Defective enzyme protein in lipoprotein lipase deficiency","volume":"19","author":"Auwerx","year":"1989","journal-title":"Eur. J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.07.030_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0022-2275(20)42756-7","article-title":"Identification of lipoprotein lipase immunoreactive protein in pre- and postheparin plasma from normal subjects and patients with type I hyperlipoproteinemia","volume":"31","author":"Kern","year":"1990","journal-title":"J.\u00a0Lipid Res."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.07.030_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0168-8227(01)00369-2","article-title":"Low lipoprotein lipase mass in preheparin serum of type 2 diabetes mellitus patients and its recovery with insulin therapy","volume":"56","author":"Miyashita","year":"2002","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.07.030_bib22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0168-8227(03)00160-8","article-title":"Gender differences in the effect of type 2 diabetes on serum lipids, pre-heparin plasma lipoprotein lipase mass and other metabolic parameters in Japanese population","volume":"62","author":"Kobayashi","year":"2003","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.07.030_bib23","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2337\/diabetes.47.6.953","article-title":"Postprandial triglyceride response in visceral obesity in men","volume":"47","author":"Couillard","year":"1998","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.07.030_bib24","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-2265.1998.00485.x","article-title":"Lipoprotein lipase mass and activity in post-heparin plasma from subjects with intra-abdominal visceral fat accumulation","volume":"48","author":"Kobayashi","year":"1998","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.07.030_bib25","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1365-2362.1999.00454.x","article-title":"Delayed post-prandial lipid metabolism in subjects with intra-abdominal visceral fat accumulation","volume":"29","author":"Taira","year":"1999","journal-title":"Eur. J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.07.030_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5551\/jat.10702","article-title":"Diagnosis and management of type I and type V hyperlipoproteinemia","volume":"19","author":"Gotoda","year":"2012","journal-title":"J.\u00a0Atheroscler. Thromb."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2017.07.030_bib27","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2337\/diab.37.5.610","article-title":"Plasma lipolytic activity. Relationship to postheparin lipolytic activity and evidence for metabolic regulation","volume":"37","author":"Eckel","year":"1988","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2017.07.030_bib28","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/0026-0495(80)90106-7","article-title":"Heterogeneity of primary lipoprotein lipase deficiency","volume":"29","author":"Brunzell","year":"1980","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2017.07.030_bib29","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/0026-0495(75)90149-3","article-title":"Reversible abnormalities in postheparin lipolytic activity during the late phase of release in diabetes mellitus (postheparin lipolytic activity in diabetes)","volume":"24","author":"Brunzell","year":"1975","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2017.07.030_bib30","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1161\/01.ATV.2.5.396","article-title":"Roles of lipoprotein lipase and hepatic triglyceride lipase in the catabolism in\u00a0vivo of triglyceride-rich lipoproteins","volume":"2","author":"Reardon","year":"1982","journal-title":"Arterioscler. Dallas Tex"},{"issue":"32","key":"10.1016\/j.atherosclerosis.2017.07.030_bib31","doi-asserted-by":"crossref","first-page":"20554","DOI":"10.1016\/S0021-9258(17)32029-X","article-title":"Kinetics of lipolysis of very low density lipoproteins by lipoprotein lipase. Importance of particle number and noncompetitive inhibition by particles with low triglyceride content","volume":"269","author":"Connelly","year":"1994","journal-title":"J.\u00a0Biol. Chem."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2017.07.030_bib32","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0022-2275(20)33411-8","article-title":"Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase","volume":"40","author":"Xiang","year":"1999","journal-title":"J.\u00a0Lipid Res."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.07.030_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0009-8981(95)06032-3","article-title":"Human triacylglycerol-rich lipoprotein subfractions as substrates for lipoprotein lipase","volume":"236","author":"Fisher","year":"1995","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.07.030_bib34","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/ATVBAHA.112.301193","article-title":"Molecular mechanisms responsible for the differential effects of apoE3 and apoE4 on plasma lipoprotein-cholesterol levels","volume":"33","author":"Li","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"25","key":"10.1016\/j.atherosclerosis.2017.07.030_bib35","doi-asserted-by":"crossref","first-page":"14791","DOI":"10.1074\/jbc.271.25.14791","article-title":"Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in\u00a0vitro and in\u00a0vivo","volume":"271","author":"Rensen","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2017.07.030_bib36","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1172\/JCI86610","article-title":"ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors","volume":"126","author":"Gordts","year":"2016","journal-title":"J.\u00a0Clin. Invest."},{"issue":"23","key":"10.1016\/j.atherosclerosis.2017.07.030_bib37","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1056\/NEJMoa1400284","article-title":"Targeting APOC3 in the familial chylomicronemia syndrome","volume":"371","author":"Gaudet","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2017.07.030_bib38","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa1400283","article-title":"Antisense inhibition of apolipoprotein C-III in patients with hypertriglyceridemia","volume":"373","author":"Gaudet","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2017.07.030_bib39","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1161\/01.ATV.13.10.1391","article-title":"Depletion of lipoprotein lipase after heparin administration","volume":"13","author":"Chevreuil","year":"1993","journal-title":"Arterioscler. Thromb. J. Vasc. Biol. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.07.030_bib40","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1067\/mlc.2001.117666","article-title":"Lipoprotein lipase during continuous heparin infusion: tissue stores become partially depleted","volume":"138","author":"N\u00e4sstr\u00f6m","year":"2001","journal-title":"J.\u00a0Lab. Clin. Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.07.030_bib41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1472-6793-4-13","article-title":"Effects of heparin on the uptake of lipoprotein lipase in rat liver","volume":"4","author":"Neuger","year":"2004","journal-title":"BMC Physiol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2017.07.030_bib42","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/01.ATV.8.5.471","article-title":"Metabolism of apolipoproteins C-II, C-III, and B in hypertriglyceridemic men. Changes after heparin-induced lipolysis","volume":"8","author":"Huff","year":"1988","journal-title":"Arterioscler. Dallas Tex"},{"key":"10.1016\/j.atherosclerosis.2017.07.030_bib43","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1701329","article-title":"Cardiovascular and metabolic effects of ANGPTL3 antisense oligonucleotides","volume":"377","author":"Graham","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2017.07.030_bib44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1612790","article-title":"Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease","volume":"377","author":"Dewey","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.07.030_bib45","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.clnu.2014.07.006","article-title":"Particle size determines effects of lipoprotein lipase on the catabolism of n-3 triglyceride-rich particles","volume":"34","author":"Xia","year":"2015","journal-title":"Clin. Nutr. Edinb Scotl"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.07.030_bib46","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1161\/01.ATV.20.1.144","article-title":"Oxidized VLDL induces less triglyceride accumulation in J774 macrophages than native VLDL due to an impaired extracellular lipolysis","volume":"20","author":"Jong","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017312170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017312170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T16:11:07Z","timestamp":1659283867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915017312170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":46,"alternative-id":["S0021915017312170"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.07.030","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alterations in plasma triglycerides lipolysis in patients with history of multifactorial chylomicronemia","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.07.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}